Health ❯ Healthcare ❯ Cancer Treatment
Dyson Cancer Centre Patient Care Prostate Cancer Treatment Metabolic Therapies Medical Equipment Glioblastoma Research Patient Support Services Proenzyme Therapy
Investors reacted to dilution risk as the deal leaves up to $99 million available over the next 12 months.